Search

Search Constraints

You searched for: Author/Creator Czauderna, Carolin

Search Results

1. Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells. Issue 5 (24th November 2021)

3. Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification. Issue 11 (14th December 2018)

4. High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma. Issue 3 (11th March 2021)

5. Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. Issue 11 (3rd September 2019)

6. Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study. Issue 12 (16th September 2021)

7. Risk Stratification in Advanced Biliary Tract Cancer: Validation of the A.L.A.N. Score. (23rd June 2020)

8. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation. Issue 10 (21st July 2022)

9. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. Issue 4 (1st May 2020)

10. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. Issue 4 (May 2020)